Cancer

Cancer

Breakthrough in HIV Vaccine Research: Largest-Scale Immunogenicity Comparison Reveals Promising Results

Researchers from the Fred Hutchinson Cancer Research Center have conducted the largest-scale cross-protocol immunogenicity comparison to date, examining 13 HIV vaccine trials conducted across nine countries worldwide. The study analyzed 36 vaccine regimens, including a polyvalent DNA prime + protein boost regimen (HVTN 124) that demonstrated exceptional immunogenicity. This regimen induced